Intelligence / Healthtech / PMA Approvals / Medtronic Cardiac Rhythm Disease Management
Medtronic Cardiac Rhythm Disease Management
4 Nov 2026: Device change approved (PMA) · Cobalt MRI ICD (DDPB3D1, DDPB3D4, DVPB3D1, DVPB3D4); Cobalt XT MRI ICD (DDPA2D1, DDPA2D4, DVPA2D1, DVPA2D4); Crome MRI I. Recorded in the openFDA device PMA data.
- Decided
- 4 Nov 2026
- Device
- Cobalt MRI ICD (DDPB3D1, DDPB3D4, DVPB3D1, DVPB3D4); Cobalt XT MRI ICD (DDPA2D1, DDPA2D4, DVPA2D1, DVPA2D4); Crome MRI I
- Specialty
- Cardiovascular
- Type
- Supplement (Normal 180 Day Track)
- Reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Reference
- P980016 S964
- Location
- Mounds View, MN
A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.
- Cardiovascular leads with 53 of 120, then Pathology (15).
- 35 added in the 30 days to 18 Nov 2026.
Find the decision makers at Medtronic Cardiac Rhythm Disease Management
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Medtronic Cardiac Rhythm Disease Management in our registers.
More in Cardiovascular
PMA Approvals
Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.